Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker

Clinical Cancer Research

Volumn 17, Issue 4, 2011, Pages 827-835

  Hofman, Véronique ^a,b,c   Bonnetaud, Christelle ^b   Ilie, Marius I ^c   Vielh, Philippe ^d   Vignaud, Jean Michel ^e   Fléjou, Jean Fraņcois ^f   Lantuejoul, Sylvie ^a   Piaton, Eric ^g   Mourad, Nadine ^h   Butori, Catherine ^a,b,c   Selva, Eric ^b   Poudenx, Michel ^b   Sibon, Stéphanie ^b   Kelhef, Sabrina ^b   Vénissac, Nicolas ^b   Jais, Jean Philippe ⁱ   Mouroux, Jérôme ^b   Molina, Thierry Jo ^j   Hofman, Paul ^a,b,c  

^a INSERM   (France)

^b PASTEUR HOSPITAL   (France)

^c Lab de Pathol Clin et Exp   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e Gustave Roussy Institut ^*  (France)

^f HÔPITAL SAINT ANTOINE   (France)

^g UNIVERSITÉ LYON 1   (France)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RECURRENCE; CELL COUNT; CELL ISOLATION; CELL SIZE; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EPITHELIAL TUMOR CELL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PREOPERATIVE PERIOD; TUMOR MARKERS, BIOLOGICAL;

EID: 79951849235     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-0445     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Goya T, Asamura H, Yoshimura H, Kato H, Shimokata K, Tsuchiya R, et al. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer 2005;50:227-34. (Pubitemid 41427898)
3. van Rens MT, de la Riviere AB, Elbers HR, Van Den Bosch JM. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000;117:374-9. (Pubitemid 30111585)
4. Naruke T, Tsuchiya R, Kondo H, Asamura H. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 2001;71:1759-64.
5. Pfannschmidt J, Muley T, Bulzebruck H, Hoffmann H, Dienemann H. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients. Lung Cancer 2007;55:371-7. (Pubitemid 46331863)
6. Strauss GM. Adjuvant chemotherapy of lung cancer: methodologic issues and therapeutic advances. Hematol Oncol Clin North Am 2005;19:263-81, vi.
7. el-Torky M, el-Zeky F, Hall JC. Significant changes in the distribution of histologic types of lung cancer. A review of 4928 cases. Cancer 1990;65:2361-7.
8. Travis WD BE, Müller-Hermelink HK, Harris CC. WHO histological classification of tumors of the lung. In: World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2004. p. 342.
9. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7. (Pubitemid 27260107)
10. Blanchon F, Grivaux M, Asselain B, Asselain B, Lebas FX, Orlando JP, et al. 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index. Lancet Oncol 2006;7:829-36. (Pubitemid 44464064)
11. Mountain CF. The International System for Staging Lung Cancer. Semin Surg Oncol 2000;18:106-15. (Pubitemid 30090451)
12. Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 2007;253:180-204. (Pubitemid 47017533)
13. Coello MC, Luketich JD, Litle VR, Godfrey TE. Prognostic significance of micrometastasis in non-small-cell lung cancer. Clin Lung Cancer 2004;5:214-25. (Pubitemid 38312737)
14. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schütze K, et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 2000;156:57-63. (Pubitemid 30644439)
15. Vona G, Estepa L, Beroud C, Damotte D, Capron F, Nalpas B, et al. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 2004;39:792-7. (Pubitemid 38337659)
16. Pinzani P, Salvadori B, Simi L, Bianchi S, Distante V, Cataliotti L, et al. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptasepolymerase chain reaction results and feasibility of molecular analysis by laser microdissection. Hum Pathol 2006;37:711-8. (Pubitemid 43956539)
17. Goldstraw P. The 7th Edition of TNM in Lung Cancer: what now? J Thorac Oncol 2009;4:671-3.
18. Modi A, Vohra HA, Weeden DF. Does surgery for primary non-small cell lung cancer and cerebral metastasis have any impact on survival? Interact Cardiovasc Thorac Surg 2009;8:467-73.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74. (Pubitemid 8054849)
20. Chen TF, Jiang GL, Fu XL, Wang LJ, Qian H, Wu KL, et al. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor. Lung Cancer 2007;56:105-14. (Pubitemid 46356633)
21. Clarke LE, Leitzel K, Smith J, Ali SM, Lipton A. Epidermal growth factor receptormRNAinperipheralbloodof patientswithpancreatic,lung,and colon carcinomas detected by RT-PCR. Int J Oncol 2003;22:425-30.
22. Gauthier LR, Granotier C, Soria JC, Faivre S, Boige V, Raymond E, et al. Detection of circulating carcinoma cells by telomerase activity. Br J Cancer 2001;84:631-5. (Pubitemid 32238996)
23. Hayes DC, Secrist H, Bangur CS, Wang T, Zhang X, Harlan D, et al. Multigene real-time PCR detection of circulating tumor cells in peripheral blood of lung cancer patients. Anticancer Res 2006;26:1567-75.
24. Kurusu Y, Yamashita J, Ogawa M. Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancer. Surgery 1999;126:820-6. (Pubitemid 29523318)
25. Peck K, Sher YP, Shih JY, Roffler SR, Wu CW, Yang PC. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients. Cancer Res 1998;58:2761-5. (Pubitemid 28311905)
26. Rolle A, Gunzel R, Pachmann U, Willen B, Hoffken K, Pachmann K. Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: a preliminary report. World J Surg Oncol 2005; 3:18.
27. Sheu CC, Yu YP, Tsai JR, Chang MY, Lin SR, Hwang JJ, et al. Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer. Int J Cancer 2006;119:1419-26.
28. Sher YP, Shih JY, Yang PC, Roffler SR, Chu YW, Wu CW, et al. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin Cancer Res 2005;11:173-9. (Pubitemid 40075792)
29. Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003;21:3902-8. (Pubitemid 46606202)
30. Sawabata N, Okumura M, Utsumi T, Inoue M, Shiono H, Minami M, et al. Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method. Gen Thorac Cardiovasc Surg 2007; 55:189-92. (Pubitemid 46742902)
31. Yamashita J, Matsuo A, Kurusu Y, Saishoji T, Hayashi N, Ogawa M. Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in nonsmall cell lung cancer: a prospective study. J Thorac Cardiovasc Surg 2002;124:299-305. (Pubitemid 35025606)
32. Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 2008;359:366-77.
33. Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, Bertolini F. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001;97:3658-61.
34. Strijbos MH, Gratama JW, Kraan J, Lamers CH, den Bakker MA, Sleijfer S. Circulating endothelial cells in oncology: pitfalls and promises. Br J Cancer 2008;98:1731-5. (Pubitemid 351748848)
35. Guddo F, Fontanini G, Reina C, Vignola AM, Angeletti A, Bonsignore G. The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression. Hum Pathol 1999;30: 788-94. (Pubitemid 29325785)
36. Pirinen R, Tammi R, Tammi M, Hirvikoski P, Parkkinen JJ, Johansson R, et al. Prognostic value of hyaluronan expression in nonsmall-cell lung cancer: increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. Int J Cancer 2001;95:12-7.